A live webcast of the event will be available on the Investors & Media section of
About
Contact:
Tel: 267.866.0114
Email: shenderson@passagebio.com
Tel: 312.961.2502
Email: mikebeyer@sambrown.com
(C) 2024 Electronic News Publishing, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.345 USD | +1.89% | -9.12% | +33.17% |
May. 15 | Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating | MT |
Mar. 04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
A live webcast of the event will be available on the Investors & Media section of
About
Contact:
Tel: 267.866.0114
Email: shenderson@passagebio.com
Tel: 312.961.2502
Email: mikebeyer@sambrown.com
(C) 2024 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+33.17% | 81.33M | |
+8.87% | 115B | |
+11.75% | 106B | |
-2.21% | 21.96B | |
-14.35% | 21.87B | |
-5.29% | 19.21B | |
-4.70% | 18.08B | |
-38.29% | 17.71B | |
+8.19% | 14.32B | |
+35.87% | 12.42B |